BriaCell Therapeutics Corp. Warrant (BCTXZ) has a negative trailing P/E of -0.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -339.04%.
Criteria proven by this page:
Overall SharesGrow Score: 40/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -117.4 | 2.90 | 252.88 | 0.00 | - |
| 2017 | -63.1 | -12.28 | 217.34 | 0.00 | - |
| 2018 | -32,009.9 | -1,141.16 | 183.34 | 0.00 | - |
| 2019 | -18,145.2 | 1,010.40 | -175.66 | 0.00 | - |
| 2020 | 49.2 | -1.55 | -20.69 | 0.00 | - |
| 2021 | -100.2 | 2.52 | 5.07 | 0.00 | - |
| 2022 | -112.1 | 2.49 | 125.71 | 0.00 | - |
| 2023 | -67.4 | 2.93 | -362.25 | 0.00 | - |
| 2024 | -25,621.4 | 326.92 | -71.14 | 0.00 | - |
| 2025 | -0.1 | 0.00 | 0.17 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.00 | $0.00 | $-1.7M | - |
| 2017 | $0.00 | $0.00 | $-2.58M | - |
| 2018 | $0.00 | $0.00 | $-4.15M | - |
| 2019 | $0.00 | $0.00 | $-4.71M | - |
| 2020 | $0.00 | $0.00 | $-4.03M | - |
| 2021 | $0.00 | $0.00 | $-13.82M | - |
| 2022 | $0.00 | $0.00 | $-26.84M | - |
| 2023 | $0.00 | $0.00 | $-20.3M | - |
| 2024 | $0.00 | $0.00 | $-4.79M | - |
| 2025 | $-86.25 | $0.00 | $-36.5M | - |
